That’s just a start.
Five years ago, Mylan offered only two oncology treatments. That number has grown more than 10-fold. And we’re not stopping.*
From solid tumors, such as breast, lung, colon and prostate, to lymphomas and leukemias, Mylan offers a wide range of chemotherapy agents. Those therapies are included as Category 1 agents in more than 30 NCCN® clinical practice guidelines.†
Our portfolio includes more than just chemotherapy.
We offer products for every stage of cancer survivorship,‡ to help stage disease and supportive care therapies that lessen the side effects of cancer treatments.2
And our growth will continue. We have a strong pipeline that contains more chemotherapy agents, the backbone of cancer care, as well as newer and more advanced product categories.*
Through innovation, we are committed to doing what's right, not what's easy—producing difficult-to-manufacture products, formulations and preparations.
Learn more about Mylan’s oncology product manufacturing capacity >